Works matching IS 2044-5385 AND VI 15 AND IP 1 AND DT 2025

Results: 55

Venetoclax-based treatment combinations in relapsed/refractory multiple myeloma: practice patterns and impact of secondary cytogenetic abnormalities on outcomes.
Published in:
Blood Cancer Journal, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41408-025-01264-2
By:
- Bolarinwa, Abiola;
- Nagaraj, Madhu;
- Zanwar, Saurabh;
- Abdallah, Nadine;
- Bergsagel, P. Leif;
- Binder, Moritz;
- Buadi, Francis;
- Chhabra, Saurabh;
- Cook, Joselle;
- Dingli, David;
- Dispenzieri, Angela;
- Gertz, Morie A.;
- Gonsalves, Wilson;
- Hayman, Suzanne;
- Kapoor, Prashant;
- Kourelis, Taxiarchis;
- Leung, Nelson;
- Lin, Yi;
- Muchtar, Eli;
- Parrondo, Ricardo
Publication type:
Article
Donor-derived CARCIK-CD19 cells engineered with Sleeping Beauty transposon in acute lymphoblastic leukemia relapsed after allogeneic transplantation.
Published in:
Blood Cancer Journal, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41408-025-01260-6
By:
- Lussana, Federico;
- Magnani, Chiara F.;
- Galimberti, Stefania;
- Gritti, Giuseppe;
- Gaipa, Giuseppe;
- Belotti, Daniela;
- Cabiati, Benedetta;
- Napolitano, Sara;
- Ferrari, Silvia;
- Moretti, Alex;
- Buracchi, Chiara;
- Borleri, Gian Maria;
- Rambaldi, Benedetta;
- Rizzuto, Giuliana;
- Grassi, Anna;
- Paganessi, Muriel;
- Meli, Cristian;
- Tettamanti, Sarah;
- Risca, Giulia;
- Pais, Giulia
Publication type:
Article
VEN in combination with 10-day DEC in newly diagnosed elderly or relapsed/refractory acute myeloid leukemia, and high-risk myelodysplastic syndrome: long term follow-up of a phase 2 trial.
Published in:
2025
By:
- Swaminathan, Mahesh;
- DiNardo, Courtney D.;
- Maiti, Abhishek;
- Pemmaraju, Naveen;
- Ohanian, Maro;
- Daver, Navel G.;
- Garcia-Manero, Guillermo;
- Issa, Ghayas C.;
- Borthakur, Gautam;
- Ravandi, Farhad;
- Montalban-Bravo, Guillermo;
- Kadia, Tapan M.;
- Alvarado, Yesid;
- Jabbour, Elias J.;
- Short, Nicholas J.;
- Wierda, William G.;
- Jain, Nitin;
- Kornblau, Steven M.;
- Masarova, Lucia;
- Pierce, Sherry A.
Publication type:
Letter
Oral decitabine cedazuridine with and without venetoclax in higher-risk myelodysplastic syndromes or chronic myelomonocytic leukemia: a propensity score–matched study.
Published in:
Blood Cancer Journal, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41408-025-01245-5
By:
- Bataller, Alex;
- Sasaki, Koji;
- Urrutia, Samuel;
- Montalban-Bravo, Guillermo;
- Bazinet, Alexandre;
- Chien, Kelly;
- Hammond, Danielle;
- Bouligny, Ian M.;
- Swaminathan, Mahesh;
- Issa, Ghayas;
- Short, Nicholas;
- Daver, Naval;
- DiNardo, Courtney D.;
- Kadia, Tapan;
- Jabbour, Elias;
- Ravandi, Farhad;
- Roboz, Gail J.;
- Savona, Michael;
- Griffiths, Elizabeth A.;
- McCloskey, James
Publication type:
Article
Symptom burden in myeloproliferative neoplasms: clinical correlates, dynamics, and survival impact—a study of 784 patients from the Quebec MPN research group.
Published in:
2025
By:
- Poullet, Alisa;
- Busque, Lambert;
- Sirhan, Shireen;
- Delage, Robert;
- Cournoyer, Ghislain;
- Chamakhi, Ines;
- Talbot, Danielle;
- Mollica, Luigina;
- Marceau, Daniele;
- Ethier, Vincent;
- Desjardins, Pierre;
- Olney, Harold J.;
- Harnois, Michaël;
- Szuber, Natasha
Publication type:
Letter
Oral decitabine cedazuridine with and without venetoclax in higher-risk myelodysplastic syndromes or chronic myelomonocytic leukemia: a propensity score–matched study.
Published in:
Blood Cancer Journal, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41408-025-01245-5
By:
- Bataller, Alex;
- Sasaki, Koji;
- Urrutia, Samuel;
- Montalban-Bravo, Guillermo;
- Bazinet, Alexandre;
- Chien, Kelly;
- Hammond, Danielle;
- Bouligny, Ian M.;
- Swaminathan, Mahesh;
- Issa, Ghayas;
- Short, Nicholas;
- Daver, Naval;
- DiNardo, Courtney D.;
- Kadia, Tapan;
- Jabbour, Elias;
- Ravandi, Farhad;
- Roboz, Gail J.;
- Savona, Michael;
- Griffiths, Elizabeth A.;
- McCloskey, James
Publication type:
Article
Venetoclax and azacitidine in untreated patients with therapy-related acute myeloid leukemia, antecedent myelodysplastic syndromes or chronic myelomonocytic leukemia.
Published in:
2025
By:
- Pullarkat, Vinod;
- Pratz, Keith W.;
- Döhner, Hartmut;
- Recher, Christian;
- Thirman, Michael J.;
- DiNardo, Courtney D.;
- Fenaux, Pierre;
- Schuh, Andre C.;
- Wei, Andrew H.;
- Pigneux, Arnaud;
- Jang, Jun-Ho;
- Juliusson, Gunnar;
- Miyazaki, Yasushi;
- Selleslag, Dominik;
- Arellano, Martha L.;
- Liu, Chenglong;
- Ridgeway, Jean A.;
- Potluri, Jalaja;
- Schuler, Jovita;
- Konopleva, Marina
Publication type:
Letter
Brain-to-vein and vein-to-vein times and outcomes in CAR T-cell therapy in myeloma.
Published in:
2025
By:
- Grischke, Tyra K.;
- Cooperrider, Jennifer H.;
- Pula, Anna;
- Sneider, Abigail;
- Yates, Samuel;
- Jakubowiak, Andrzej J.;
- Derman, Benjamin A.
Publication type:
Letter
Carfilzomib prescribing patterns and outcomes for relapsed or refractory multiple myeloma: a real-world analysis.
Published in:
Blood Cancer Journal, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41408-025-01256-2
By:
- Dong, Sharlene;
- Banerjee, Rahul;
- Khan, Adeel M.;
- Wang, Mengru;
- Wang, Xiaoliang;
- Afghahi, Anosheh;
- Afrough, Aimaz;
- Janakiram, Murali;
- Wang, Bo;
- Cowan, Andrew J.;
- Sperling, Adam S.;
- Anderson Jr, Larry D.;
- Rajkumar, S. Vincent;
- Kaur, Gurbakhash
Publication type:
Article
Deep immune cell profiling in blood and bone marrow of early stage monoclonal gammopathy: an iStopMM and ECRIN-M3 collaborative study.
Published in:
2025
By:
- Pérez-Escurza, Oihane;
- Flores-Montero, Juan;
- Óskarsson, Jón Þórir;
- Sanoja-Flores, Luzalba;
- Pozo, Julio;
- Lécrevisse, Quentin;
- Martín, Silvia;
- Reed, Elín Ruth;
- Hákonardóttir, Guðlaug Katrín;
- Harding, Stephen;
- Þorsteinsdóttir, Sigrún;
- Rögnvaldsson, Sæmundur;
- Love, Thorvardur Jon;
- Durie, Brian;
- Kristinsson, Sigurdur Yngvi;
- Orfao, Alberto
Publication type:
Letter
Treatment with obinutuzumab plus venetoclax reshapes the TRB repertoire of CLL patients.
Published in:
Blood Cancer Journal, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41408-025-01209-9
By:
- Hengeveld, Paul J.;
- Schilperoord-Vermeulen, Joyce;
- Kolijn, P. Martijn;
- Dubois, Julie M. N.;
- Westerweel, Peter E.;
- Kersting, Sabina;
- Kater, Arnon P.;
- Levin, Mark-David;
- Langerak, Anton W.
Publication type:
Article
Refining precision prognostics in multiple myeloma: loss of miR-221/222 cluster in CD138+ plasma cells results in short-term progression and worse treatment outcome.
Published in:
Blood Cancer Journal, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41408-025-01248-2
By:
- Soureas, Konstantinos;
- Malandrakis, Panagiotis;
- Papadimitriou, Maria-Alexandra;
- Minopoulos, Christos;
- Ntanasis-Stathopoulos, Ioannis;
- Liacos, Christine-Ivy;
- Gavriatopoulou, Maria;
- Kastritis, Efstathios;
- Dimopoulos, Meletios-Athanasios;
- Scorilas, Andreas;
- Avgeris, Margaritis;
- Terpos, Evangelos
Publication type:
Article
Double hit & double expressor lymphomas: a multicenter analysis of survival outcomes with CD19-directed CAR T-cell therapy.
Published in:
Blood Cancer Journal, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41408-025-01250-8
By:
- Karmali, Reem;
- Shouse, Geoffrey;
- Torka, Pallawi;
- Moyo, Tamara K.;
- Romancik, Jason;
- Barta, Stefan K.;
- Bhansali, Rahul;
- Cohen, Jonathon B.;
- Shah, Nirav N.;
- Zurko, Joanna;
- Kenkre, Vaishalee P.;
- Hess, Brian;
- Stephens, Deborah M.;
- Fitzgerald, Lindsey;
- Ollila, Thomas;
- Tabiti, Bukky;
- Roy, Ishan;
- Ma, Shuo;
- Winter, Jane;
- Pro, Barbara
Publication type:
Article
Correction: The clinical journey of belantamab mafodotin in relapsed or refractory multiple myeloma: lessons in drug development.
Published in:
2025
By:
- Mukhopadhyay, Pralay;
- Abdullah, Hesham A.;
- Opalinska, Joanna B.;
- Paka, Prani;
- Richards, Eric;
- Weisel, Katja;
- Trudel, Suzanne;
- Mateos, Maria-Victoria;
- Dimopoulos, Meletios Athanasios;
- Lonial, Sagar
Publication type:
Correction Notice
Allo-HCT refined ELN 2022 risk classification: validation of the Adverse-Plus risk group in AML patients undergoing allogeneic hematopoietic cell transplantation within the Spanish Group for Hematopoietic Cell Transplantation (GETH-TC).
Published in:
Blood Cancer Journal, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41408-025-01223-x
By:
- Jiménez-Vicente, Carlos;
- Esteve, Jordi;
- Baile-González, Mónica;
- Pérez-López, Estefanía;
- Martin Calvo, Carmen;
- Aparicio, Clara;
- Oiartzabal Ormategi, Itziar;
- Esquirol, Albert;
- Peña-Muñoz, Felipe;
- Fernández-Luis, Sara;
- Heras Fernando, Inmaculada;
- González-Rodríguez, Ana Pilar;
- López-García, Alberto;
- López-Lorenzo, Jose Luis;
- Torrado, Tamara;
- Sáez Marín, Adolfo Jesús;
- Acosta Fleytas, Cynthia;
- García, Lucía;
- Villar, Sara;
- Filaferro, Silvia
Publication type:
Article
Superior preclinical efficacy of co-treatment with BRG1/BRM and FLT3 inhibitor against AML cells with FLT3 mutations.
Published in:
Blood Cancer Journal, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41408-025-01251-7
By:
- Fiskus, Warren;
- Mill, Christopher P.;
- Piel, Jessica;
- Collins, Mike;
- Hentemann, Murphy;
- Cuglievan, Branko;
- Birdwell, Christine E.;
- Das, Kaberi;
- Hou, Hanxi;
- Davis, John A.;
- Jain, Antrix;
- Malovannaya, Anna;
- Kadia, Tapan M.;
- Daver, Naval;
- Sasaki, Koji;
- Takahashi, Koichi;
- Hammond, Danielle;
- Reville, Patrick K.;
- Flores, Lauren B.;
- Loghavi, Sanam
Publication type:
Article
Outcomes in patients with classic Hodgkin lymphoma refractory or intolerant to brentuximab vedotin and anti-PD-1 therapy: a real world analysis from 15 U.S. academic centers.
Published in:
Blood Cancer Journal, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41408-025-01257-1
By:
- Voorhees, Timothy J.;
- McLaughlin, Eric M.;
- Torka, Pallawi;
- Florindez, Jorge;
- Kim, Na Hyun;
- Moyo, Tamara K.;
- Reves, Heather;
- Sumransub, Nuttavut;
- Deshpande, Saarang;
- Rose, Ashley;
- Duarte, Cassandra;
- Faisal, Muhammad Salman;
- Hamid, Showkat;
- Subbiah, Suki;
- Ayyappan, Sabarish;
- Shea, Lauren;
- Cortese, Matt;
- Patel, Krish;
- Major, Ajay;
- Saeed, Hayder
Publication type:
Article
Characteristics and predictors of central nervous system relapse in newly diagnosed acute promyelocytic leukemia in the era of arsenic: a 13-year monocenter cohort study.
Published in:
Blood Cancer Journal, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41408-025-01247-3
By:
- Jiang, Bingqian;
- Tong, Hongyan;
- Meng, Haitao;
- Xie, Wanzhuo;
- Yu, Wenjuan;
- Huang, Jian;
- Wang, Huafeng;
- You, Liangshun;
- Mao, Liping;
- Yang, Min;
- Qian, Jiejing;
- Ren, Yanling;
- Yang, Chunmei;
- Ma, Liya;
- Jin, Jie;
- Lou, Yinjun
Publication type:
Article
Switching TKIs during CML therapy is frequent, mostly driven by intolerance, and does not affect survival: a prospective Quebec registry study.
Published in:
Blood Cancer Journal, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41408-025-01242-8
By:
- Busque, Lambert;
- Beaudet, Marc-Étienne;
- Harnois, Michaël;
- Moussa, Hanane;
- Szuber, Natasha;
- Mollica, Luigina;
- Delage, Robert;
- Olney, Harold;
- Laneuville, Pierre;
- Cournoyer, Ghislain;
- Chamakhi, Inès;
- Lalancette, Marc;
- Talbot, Danielle;
- Ethier, Vincent;
- Desjardins, Pierre;
- Assouline, Sarit
Publication type:
Article
Daratumumab-based quadruplet versus triplet induction regimens in transplant-eligible newly diagnosed multiple myeloma: a systematic review and meta-analysis.
Published in:
Blood Cancer Journal, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41408-025-01253-5
By:
- Souto Filho, João Tadeu Damian;
- Cantadori, Lucas Oliveira;
- Crusoe, Edvan de Queiroz;
- Hungria, Vania;
- Maiolino, Angelo
Publication type:
Article
Correction: Multiple myeloma as a challenging multidimensional random process: a data-driven web-based application for treatment selection.
Published in:
2025
By:
- Luchinin, Alexander S.;
- Gevorkyan, Tigran G.;
- Semenova, Anastasia A.
Publication type:
Correction Notice
Switching TKIs during CML therapy is frequent, mostly driven by intolerance, and does not affect survival: a prospective Quebec registry study.
Published in:
Blood Cancer Journal, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41408-025-01242-8
By:
- Busque, Lambert;
- Beaudet, Marc-Étienne;
- Harnois, Michaël;
- Moussa, Hanane;
- Szuber, Natasha;
- Mollica, Luigina;
- Delage, Robert;
- Olney, Harold;
- Laneuville, Pierre;
- Cournoyer, Ghislain;
- Chamakhi, Inès;
- Lalancette, Marc;
- Talbot, Danielle;
- Ethier, Vincent;
- Desjardins, Pierre;
- Assouline, Sarit
Publication type:
Article
Multiple myeloma as a challenging multidimensional random process: a data-driven web-based application for treatment selection.
Published in:
Blood Cancer Journal, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41408-025-01238-4
By:
- Luchinin, Alexander S.;
- Gevorkyan, Tigran G.;
- Semenova, Anastasia A.
Publication type:
Article
Outcomes and prognostic factors in patients with Burkitt lymphoma/leukemia in adolescents and adults: an experience from hematology cancer consortium.
Published in:
Blood Cancer Journal, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41408-025-01240-w
By:
- Rajendra, Akhil;
- Sengar, Manju;
- Korula, Anu;
- Ganesan, Prasanth;
- Jain, Hasmukh;
- K, Divya;
- Samuel, Prasanna;
- Perumal Kalaiyarasi, Jayachandran;
- Prakash, Gaurav;
- John, M. Joseph;
- Palassery, Rasmi;
- Nair, Chandran K.;
- Shet, Tanuja;
- Selvarajan, Sushil;
- Nayak, Lingaraj;
- Karunakaran, Parathan;
- Fouzia, N. A.;
- Prakash, Om;
- Bagal, Bhausaheb;
- Mehra, Nikita
Publication type:
Article
A real-world experience of efficacy and safety of belantamab mafodotin in relapsed refractory multiple myeloma.
Published in:
Blood Cancer Journal, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41408-025-01226-8
By:
- Dileo, Rachel;
- Mewawalla, Prerna;
- Babu, Kalaivani;
- Yin, Yue;
- Strouse, Christopher;
- Chen, Ethan;
- Shaikh, Hira;
- Davis, James A.;
- Green, Kimberly M.;
- Alkharabsheh, Omar;
- Rashid, Aliya;
- Pokhrel, Bidushi;
- Ahmed, Nausheen;
- Abdallah, Al-Ola;
- Hashmi, Hamza
Publication type:
Article
Different definitions in intention-to-treat analysis for chimeric antigen receptor T-cell therapy depend on research scope.
Published in:
Blood Cancer Journal, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41408-025-01246-4
By:
- Argnani, Lisa;
- Casadei, Beatrice;
- Zinzani, Pier Luigi
Publication type:
Article
Evolution of WHO diagnostic criteria in "Classical Myeloproliferative Neoplasms" compared with the International Consensus Classification.
Published in:
Blood Cancer Journal, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41408-025-01235-7
By:
- Thiele, Jürgen;
- Kvasnicka, Hans Michael;
- Gianelli, Umberto;
- Arber, Daniel A.;
- Tefferi, Ayalew;
- Vannucchi, Alessandro M.;
- Barbui, Tiziano;
- Orazi, Attilio
Publication type:
Article
Risk factors for CAR T-cell manufacturing failure and patient outcomes in large B-cell lymphoma: a report from the UK National CAR T Panel.
Published in:
Blood Cancer Journal, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41408-025-01225-9
By:
- Dulobdas, Vaishali;
- Kirkwood, Amy A.;
- Serpenti, Fabio;
- Gautama, Brijesh;
- Panopoulou, Aikaterini;
- Mathew, Amrith;
- Gabriel, Sumantha;
- Malladi, Ram;
- Pealing, Jessica;
- Bonney, Denise;
- Nicholson, Emma;
- Besley, Caroline;
- Ghorashian, Sara;
- Kuhnl, Andrea;
- Davies, Elizabeth;
- Chappell, Jackie;
- Black, Anne;
- Menne, Tobias;
- O'Reilly, Maeve A.;
- Sanderson, Robin
Publication type:
Article
Dexamethasone for the management of CRS Related to teclistamab in patients with relapsed/refractory multiple myeloma.
Published in:
Blood Cancer Journal, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41408-025-01222-y
By:
- Davis, James A.;
- Snyder, Jordan;
- Rice, Mikhaila;
- Moore, Donald C.;
- Cahoon, Christopher;
- Julian, Kelley;
- Wagner, Charlotte B.;
- Granger, Katelynn;
- Green, Kimberly M.;
- Atrash, Shebli;
- Hill, Hailey;
- McElwee, Jessica;
- Elsey, Grace;
- Khouri, Jack;
- Rudoni, Joslyn;
- Mahmoudjafari, Zahra;
- Nachar, Victoria R.
Publication type:
Article
Risk factors for CAR T-cell manufacturing failure and patient outcomes in large B-cell lymphoma: a report from the UK National CAR T Panel.
Published in:
Blood Cancer Journal, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41408-025-01225-9
By:
- Dulobdas, Vaishali;
- Kirkwood, Amy A.;
- Serpenti, Fabio;
- Gautama, Brijesh;
- Panopoulou, Aikaterini;
- Mathew, Amrith;
- Gabriel, Sumantha;
- Malladi, Ram;
- Pealing, Jessica;
- Bonney, Denise;
- Nicholson, Emma;
- Besley, Caroline;
- Ghorashian, Sara;
- Kuhnl, Andrea;
- Davies, Elizabeth;
- Chappell, Jackie;
- Black, Anne;
- Menne, Tobias;
- O'Reilly, Maeve A.;
- Sanderson, Robin
Publication type:
Article
Myeloid neoplasms with MYC-positive double minutes: towards recognition as a distinct entity.
Published in:
Blood Cancer Journal, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41408-025-01244-6
By:
- Summerer, Isolde;
- Walter, Wencke;
- Meggendorfer, Manja;
- Haferlach, Torsten;
- Dicker, Frank;
- Hutter, Stephan;
- Nadarajah, Niroshan;
- Stengel, Anna;
- Kuehn, Constanze;
- Kern, Wolfgang;
- Bennett, John M.;
- Haferlach, Claudia;
- Pohlkamp, Christian
Publication type:
Article
Myeloid neoplasms with PHF6 mutations: context-dependent genomic and prognostic characterization in 176 informative cases.
Published in:
Blood Cancer Journal, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41408-025-01231-x
By:
- Fathima, Saubia;
- Alsugair, Ali;
- He, Rong;
- Mangaonkar, Abhishek A.;
- Begna, Kebede H.;
- Pardanani, Animesh;
- Zepeda Mendoza, Cinthya J.;
- Reichard, Kaaren K.;
- Gangat, Naseema;
- Tefferi, Ayalew
Publication type:
Article
Impact of baseline genetic profile and treatment on outcome and hematological toxicity in CEBPA-mutated AML.
Published in:
Blood Cancer Journal, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41408-025-01224-w
By:
- Mannelli, Francesco;
- Piccini, Matteo;
- Frigeni, Marco;
- Gianfaldoni, Giacomo;
- Bencini, Sara;
- Salmoiraghi, Silvia;
- Scappini, Barbara;
- Peruzzi, Benedetta;
- Caporale, Roberto;
- Ciolli, Gaia;
- Crupi, Francesca;
- Fasano, Laura;
- Quinti, Elisa;
- Pasquini, Andrea;
- Caroprese, Jessica;
- Vanderwert, Fiorenza;
- Rotunno, Giada;
- Pancani, Fabiana;
- Signori, Leonardo;
- Tarantino, Danilo
Publication type:
Article
Targeting osteoclasts for treatment of high-risk B-cell acute lymphoblastic leukemia.
Published in:
Blood Cancer Journal, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41408-025-01239-3
By:
- Kotecha, Rishi S.;
- Trinder, Sarah M.;
- Hughes, Anastasia M.;
- Mullin, Benjamin H.;
- Rashid, Sarah;
- Yuan, Jinbo;
- Xu, Jiake;
- Duncan, Owen;
- Skut, Patrycja;
- Chua, Grace-Alyssa;
- Singh, Sajla;
- Oommen, Joyce;
- Lock, Richard B.;
- Kees, Ursula R.;
- Malinge, Sebastien;
- Kuek, Vincent;
- Cheung, Laurence C.
Publication type:
Article
Multiple myeloma as a challenging multidimensional random process: a data-driven web-based application for treatment selection.
Published in:
Blood Cancer Journal, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41408-025-01238-4
By:
- Luchinin, Alexander S.;
- Gevorkyan, Tigran G.;
- Semenova, Anastasia A.
Publication type:
Article
Outcomes of patients with Richter transformation who received no prior chemoimmunotherapy for their CLL.
Published in:
Blood Cancer Journal, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41408-025-01236-6
By:
- Kittai, Adam S.;
- Huang, Ying;
- Miller, Sarah;
- Allan, John N.;
- Bhat, Seema A.;
- Bond, David A.;
- Brander, Danielle M.;
- Byrd, John C.;
- Chavez, Julio C.;
- Chong, Elise;
- Davids, Matthew S.;
- Danilov, Alexey V.;
- Ding, Wei;
- Dowling, Mark R.;
- Dvorak-Kornaus, Kaitlyn;
- Freedman, Hannah;
- Hampel, Paul J.;
- Ho, Carrie;
- Hwang, Steven R.;
- Islam, Prioty
Publication type:
Article
High WEE1 expression is independently linked to poor survival in multiple myeloma.
Published in:
Blood Cancer Journal, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41408-025-01230-y
By:
- Simhal, Anish K.;
- Firestone, Ross S.;
- Oh, Jung Hun;
- Avutu, Viswatej;
- Norton, Larry;
- Hultcrantz, Malin;
- Usmani, Saad Z.;
- Maclachlan, Kylee H.;
- Deasy, Joseph O.
Publication type:
Article
Lenalidomide combined with R-CHOP (R2-CHOP) in the treatment of newly diagnosed double-expressor diffuse large B-cell lymphoma: a prospective phase II clinical trial.
Published in:
Blood Cancer Journal, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41408-025-01229-5
By:
- Liu, Yizhen;
- Zhang, Qunling;
- Lv, Fangfang;
- Liu, Xiaojian;
- Ji, Dongmei;
- Xia, Zuguang;
- Jin, Jia;
- Tao, Rong;
- Zhang, Wenhao;
- Li, Xiaoqiu;
- Zhang, Shengjian;
- Wang, Zezhou;
- Wang, Jiachen;
- Hong, Xiaonan;
- Cao, Junning
Publication type:
Article
Effect of pre-transplant cytoreductive therapy on the outcomes of patients with MDS or secondary AML evolving from MDS undergoing allo-HSCT: a secondary analysis of an RCT.
Published in:
Blood Cancer Journal, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41408-025-01233-9
By:
- Xue, Rongtao;
- Dai, Min;
- Jiang, Erlie;
- Ou, Xueying;
- Huang, Fen;
- Fan, Zhiping;
- Xu, Na;
- Yan, Chenhua;
- Nie, Danian;
- Liang, Xinquan;
- Chen, Hong;
- Ye, Jieyu;
- Jiang, Ling;
- Liu, Hui;
- Jin, Hua;
- Lin, Ren;
- Zhang, Yu;
- Sun, Jing;
- Han, Mingzhe;
- Liu, Qifa
Publication type:
Article
Clonal plasma cell proportion in the synthetic phase identifies a unique high-risk cohort in multiple myeloma.
Published in:
Blood Cancer Journal, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41408-025-01232-w
By:
- Zanwar, Saurabh;
- Jevremovic, Dragan;
- Kapoor, Prashant;
- Olteanu, Horatiu;
- Buadi, Francis;
- Horna, Pedro;
- Gonsalves, Wilson;
- Otteson, Gregory;
- Bolarinwa, Abiola Bukunmi;
- Hayman, Suzanne;
- Abdallah, Nadine;
- Binder, Moritz;
- Cook, Joselle;
- Dispenzieri, Angela;
- Dingli, David;
- Gertz, Morie A.;
- Kourelis, Taxiarchis;
- Leung, Nelson;
- Lin, Yi;
- Muchtar, Eli
Publication type:
Article
Decitabine with etoposide is effective in TP53 mutated myeloid tumors via overcoming differentiation block.
Published in:
Blood Cancer Journal, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41408-025-01228-6
By:
- Ma, Jiexian;
- Sun, Shunrong;
- Xie, Yanhui;
- Zhou, Songlin;
- Wu, Min;
- Zuo, Xinyu;
- Xie, Mixue;
- Wang, Xiaoqin
Publication type:
Article
Correction: A simplified, two-factor clinical prognostic scoring system for patients with newly diagnosed Hodgkins Lymphoma.
Published in:
2025
By:
- Singh, Charanpreet;
- KS, Lekshmon;
- Jain, Arihant;
- Lad, Deepesh;
- Khadwal, Alka;
- Basher, Rajender;
- Bal, Amanjit;
- Srinivasan, Radhika;
- Varma, Subhash;
- Malhotra, Pankaj;
- Prakash, Gaurav
Publication type:
Correction Notice
Comparing the efficacy and safety of venetoclax combined with hypomethylating agents versus intensive chemotherapy as induction therapy in newly diagnosed core binding factor acute myeloid leukemia patients.
Published in:
Blood Cancer Journal, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41408-025-01227-7
By:
- Shen, Jingyi;
- Shan, Meng;
- Chu, Mengqian;
- Cai, Yiming;
- Rui, Jingwen;
- Chen, Suning;
- Wu, Depei;
- Xu, Yang
Publication type:
Article
Genomic characterization of chronic lymphocytic leukemia in patients of African ancestry.
Published in:
Blood Cancer Journal, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41408-024-01207-3
By:
- Bonolo de Campos, Cecilia;
- McCabe, Chantal E.;
- Bruins, Laura A.;
- O'Brien, Daniel R.;
- Brown, Sochilt;
- Tschumper, Renee C.;
- Allmer, Cristine;
- Zhu, Yuan Xiao;
- Rabe, Kari G.;
- Parikh, Sameer A.;
- Kay, Neil E.;
- Yan, Huihuang;
- Cerhan, James R.;
- Allan, John N.;
- Furman, Richard R.;
- Weinberg, J. Brice;
- Brander, Danielle M.;
- Jelinek, Diane F.;
- Chesi, Marta;
- Slager, Susan L.
Publication type:
Article
Defining 'Intention' in intention-to-treat survival outcomes for chimeric antigen receptor T-cell therapy.
Published in:
Blood Cancer Journal, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41408-025-01220-0
By:
- Milrod, Charles J.;
- Steuer, Rebecca;
- Pelcovits, Ari
Publication type:
Article
The clinical journey of belantamab mafodotin in relapsed or refractory multiple myeloma: lessons in drug development.
Published in:
Blood Cancer Journal, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41408-025-01212-0
By:
- Mukhopadhyay, Pralay;
- Abdullah, Hesham A.;
- Opalinska, Joanna B.;
- Paka, Prani;
- Richards, Eric;
- Weisel, Katja;
- Trudel, Suzanne;
- Mateos, Maria-Victoria;
- Dimopoulos, Meletios Athanasios;
- Lonial, Sagar
Publication type:
Article
Bruton's tyrosine kinase inhibition re-sensitizes multidrug-resistant DLBCL tumors driven by BCL10 gain-of-function mutants to venetoclax.
Published in:
Blood Cancer Journal, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41408-025-01214-y
By:
- Coughlin, Caroline A.;
- Chahar, Dhanvantri;
- Lekakis, Marianna;
- Youssfi, Abdessamad A.;
- Li, Lingxiao;
- Roberts, Evan;
- Gallego, Natalia Campos;
- Volmar, Claude-Henry;
- Landgren, Ola;
- Brothers, Shaun;
- Griswold, Anthony J.;
- Amador, Catalina;
- Bilbao, Daniel;
- Maura, Francesco;
- Schatz, Jonathan H.
Publication type:
Article
CALR<sup>ins5</sup>-mediated clonal hematopoiesis causes severe hemolytic anemia in a female PGK1<sup>Ser320Asn</sup> carrier.
Published in:
Blood Cancer Journal, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41408-025-01216-w
By:
- Morales, M. L.;
- Cano, H.;
- de la Morena-Barrio, B.;
- Vives-Corrons, J. L.;
- Cuenca-Zamora, E. J.;
- Garrido-Rodríguez, P.;
- Bento, C.;
- Pereira, J.;
- Martínez Nieto, J.;
- Chen-Liang, T. H.;
- Fuster, J. L.;
- Caracena, S.;
- Lozano, M. L.;
- Teruel-Montoya, R.;
- Corral, J.;
- Ferrer-Marín, F.
Publication type:
Article
GATA2 mutated allele specific expression is associated with a hyporesponsive state of HSC in GATA2 deficiency syndrome.
Published in:
Blood Cancer Journal, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41408-025-01213-z
By:
- Largeaud, Laetitia;
- Fregona, Vincent;
- Jamrog, Laura A.;
- Hamelle, Camille;
- Dufrechou, Stéphanie;
- Prade, Naïs;
- Sellam, Esmaa;
- Enfedaque, Pauline;
- Bayet, Manon;
- Hébrard, Sylvie;
- Bouttier, Mathieu;
- Didier, Christine;
- Gerby, Bastien;
- Delabesse, Eric;
- Pasquet, Marlène;
- Broccardo, Cyril
Publication type:
Article
Fedratinib for the treatment of myelofibrosis: a critical appraisal of clinical trial and "real-world" data.
Published in:
Blood Cancer Journal, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41408-025-01211-1
By:
- Duek, Adrian;
- Leviatan, Ilona;
- Jarchowsky Dolberg, Osnat;
- Ellis, Martin H.
Publication type:
Article